In the first half of 2026, China’s National Health Commission (NHC) issued two “Three New Foods” announcements (Announcement No. 1 and Announcement No. 5 of 2026), approving a total of 38 products, including new food raw materials, new food additives, and new food-related products. Among these, 18 were approved as new food additives.

On July 13, 2026, China National Center for Food Safety Risk Assessment (CFSA) issued 4 new food materials. Comments are welcomed before August 12, 2026.

On July 6, Henan Zhongda Hengyuan Biotechnology Stock Co., Ltd. (Hengyuan) received a "no questions" letter from the FDA regarding the GRAS (Generally Recognized as Safe) notice for its D-psicose. Produced via an enzymatic bioconversion process, the ingredient's safety has now been officially recognized by the FDA.

In the first half of 2026, China’s National Health Commission (NHC) issued two “Three New Foods” announcements (Announcement No. 1 and Announcement No. 5 of 2026), approving a total of 38 products, including new food raw materials, new food additives, and new food-related products. Among these, 12 were approved as new food raw materials. In addition, seven new food ingredients were added to the Termination of Review List, while five new food ingredients entered the public consultation stage.

China NHC issued notifications regarding the acceptance of “three new foods”. The applications for 2 new food materials and 1 new food additives have been received.

In order to help enterprises better understand the filing status of health food (dietary supplements) in China, CIRS has gathered statistics on health foods approved in 2026 (as of June 30) and analyzed them from multiple perspectives.

GACC Decree No. 280 was promulgated on October 14, 2025, and officially entered into force on June 1, 2026.

With the first half of 2026 concluded, Chinese ingredient companies are demonstrating strong momentum in GRAS notices; the number of approvals secured in this period alone (16) rivals the total for the entire year of 2025 (19). Drawing on publicly available FDA GRAS notice data, CIRS Group has compiled updates from January to June. By systematically reviewing metrics such as total volume, ingredient categories, outcomes, and the origins of applicants, CIRS provides valuable insights for food ingredient companies looking to enter the U.S. market.

According to the information released by the Center for Food Evaluation of the State Administration for Market Regulation and the Special Food Information Query Platform, a total of 1136 health food registration approvals were issued in the first half of 2026. Among these, 121 were for new health food products, including 3 imported products.

The State Administration for Market Regulation has revised and drafted the Detailed Rules for the Review of Production Licensing for Infant and Young Child Complementary Foods (Draft for Comment) and is now soliciting public opinion. The deadline for submitting comments is August 1, 2026.